BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2087244)

  • 1. Detection of function-associated molecules on rat leukemic NK cells: activation by monoclonal antibody or phorbol ester.
    Evans DL; Harris DT; Staton DL; Jaso-Friedmann L
    Nat Immun Cell Growth Regul; 1990; 9(6):353-65. PubMed ID: 2087244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL; Patel SS; Lipsky PE
    J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for triggering of lysis by cytolytic T lymphocyte clones.
    Lancki DW; Weiss A; Fitch FW
    J Immunol; 1987 Jun; 138(11):3646-53. PubMed ID: 2953785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction in activated natural killer cells and natural killer cells inactivated with sensitive targets.
    Gibboney JJ; Shenoy AM; Jin X; Brahmi Z
    Nat Immun; 1992; 11(2):57-68. PubMed ID: 1498520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
    Poggi A; Pardi R; Pella N; Morelli L; Sivori S; Vitale M; Revello V; Moretta A; Moretta L
    Eur J Immunol; 1993 Oct; 23(10):2454-63. PubMed ID: 8405045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane signaling during natural killer cell-mediated cytotoxicity. Regulation by protein kinase C activation.
    Leibson PJ; Midthun DE; Windebank KP; Abraham RT
    J Immunol; 1990 Sep; 145(5):1498-504. PubMed ID: 2166762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
    Karlhofer FM; Yokoyama WM
    J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    Teng JM; Liu XR; Mills GB; Dupont B
    J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
    Rabinowich H; Lin WC; Herberman RB; Whiteside TL
    J Immunol; 1994 Oct; 153(8):3504-13. PubMed ID: 7523496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
    Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
    Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L; Lemieux S
    J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
    Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
    J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
    Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
    J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester.
    Nishimura T; Burakoff SJ; Herrmann SH
    J Immunol; 1989 Mar; 142(6):2155-61. PubMed ID: 2646377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of protein kinase C in the rat basophilic leukemia (RBL-2H3) cell reveal that antigen-induced signals are not mimicked by the actions of phorbol myristate acetate and Ca2+ ionophore.
    Cunha-Melo JR; Gonzaga HM; Ali H; Huang FL; Huang KP; Beaven MA
    J Immunol; 1989 Oct; 143(8):2617-25. PubMed ID: 2551964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
    Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
    J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.